secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2025-09-10T23:59:59+00:00
Accession:  0001262104-25-000009
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma rebrands as Lite Strategy, Inc., adopts digital asset treasury with LTC
--------------------------------------------------------------------------------

- Company changes name to Lite Strategy, Inc.; NASDAQ ticker changes from MEIP to LITS effective Sep 11, 2025.
- Holds over $100M in Litecoin (LTC) as primary reserve asset; advised by GSR for liquidity and risk management.
- LTC creator Charlie Lee joins board; continues preclinical evaluation of voruciclib and zandelisib.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000126210425000009/0001262104-25-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000126210425000009/meip-20250910.htm
  HTML page:      https://secwatch.observer/filing/0001262104-25-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer